RLAY FY 2021 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-96.3% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$365M-12040.2% margin

Net Income

-$364M-12012.9% margin

EPS (Diluted)

$-3.82

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$78M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$111M

Stockholders' Equity

$898M

Cash & Equivalents

$280M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$83M	-96.3%
Gross Profit	$3M	$79M	-96.2%
Operating Income	-$365M	-$56M	-553.6%
Net Income	-$364M	-$52M	-594.3%